These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22187651)

  • 1. Effects of Selected Anionic β-Cyclodextrins on Persistence of Blood Glucose Lowering by Insulin Glargine after Subcutaneous Injection to Rats.
    Uehata K; Anno T; Hayashida K; Motoyama K; Higashi T; Hirayama F; Ono N; Pipkin JD; Uekama K; Arima H
    J Drug Deliv; 2011; 2011():195146. PubMed ID: 22187651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sulfobutyl ether-β-cyclodextrin on bioavailability of insulin glargine and blood glucose level after subcutaneous injection to rats.
    Uehata K; Anno T; Hayashida K; Motoyama K; Hirayama F; Ono N; Pipkin JD; Uekama K; Arima H
    Int J Pharm; 2011 Oct; 419(1-2):71-6. PubMed ID: 21803140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peak-less hypoglycemic effect of insulin glargine by complexation with maltosyl-β-cyclodextrin.
    Uehata K; Anno T; Hayashida K; Higashi T; Motoyama K; Hirayama F; Uekama K; Arima H
    Int J Pharm; 2012 Jan; 422(1-2):33-9. PubMed ID: 22020273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified beta-cyclodextrin (SBE7-beta-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits.
    Jarho P; Järvinen K; Urtti A; Stella VJ; Järvinen T
    J Pharm Pharmacol; 1996 Mar; 48(3):263-9. PubMed ID: 8737051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of sulfobutyl ether beta-cyclodextrin on DY-9760e-induced cellular damage: In vitro and in vivo studies.
    Nagase Y; Arima H; Wada K; Sugawara T; Satoh H; Hirayama F; Uekama K
    J Pharm Sci; 2003 Dec; 92(12):2466-74. PubMed ID: 14603492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of subcutaneous bioavailability of insulin by sulphobutyl ether beta-cyclodextrin in rats.
    Tokihiro K; Arima H; Tajiri S; Irie T; Hirayama F; Uekama K
    J Pharm Pharmacol; 2000 Aug; 52(8):911-7. PubMed ID: 11007061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Water-soluble beta-cyclodextrins in paediatric oral solutions of spironolactone: preclinical evaluation of spironolactone bioavailability from solutions of beta-cyclodextrin derivatives in rats.
    Kaukonen AM; Lennernäs H; Mannermaa JP
    J Pharm Pharmacol; 1998 Jun; 50(6):611-9. PubMed ID: 9680070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of sulfobutyl ether beta-cyclodextrin on DY-9760e-induced hemolysis in vitro.
    Nagase Y; Hirata M; Arima H; Tajiri S; Nishimoto Y; Hirayama F; Irie T; Uekama K
    J Pharm Sci; 2002 Nov; 91(11):2382-9. PubMed ID: 12379923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioadhesive tablets containing cyclodextrin complex of itraconazole for the treatment of vaginal candidiasis.
    Cevher E; Açma A; Sinani G; Aksu B; Zloh M; Mülazımoğlu L
    Int J Biol Macromol; 2014 Aug; 69():124-36. PubMed ID: 24857873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced absorption of cyclosporin A by complexation with dimethyl-beta-cyclodextrin in bile duct-cannulated and -noncannulated rats.
    Miyake K; Arima H; Irie T; Hirayama F; Uekama K
    Biol Pharm Bull; 1999 Jan; 22(1):66-72. PubMed ID: 9989664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin.
    Miyake K; Arima H; Hirayama F; Yamamoto M; Horikawa T; Sumiyoshi H; Noda S; Uekama K
    Pharm Dev Technol; 2000; 5(3):399-407. PubMed ID: 10934740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the inclusion mode of beta-cyclodextrin sulfate and its effect on the chlorpromazine-induced hemolysis of rabbit erythrocytes.
    Shiotani K; Uehata K; Irie T; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1994 Nov; 42(11):2332-7. PubMed ID: 7859332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.
    Arima H; Yunomae K; Miyake K; Irie T; Hirayama F; Uekama K
    J Pharm Sci; 2001 Jun; 90(6):690-701. PubMed ID: 11357172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aluminium beta-cyclodextrin sulphate as a stabilizer and sustained-release carrier for basic fibroblast growth factor.
    Fukunaga K; Hijikata S; Ishimura K; Sonoda R; Irie T; Uekama K
    J Pharm Pharmacol; 1994 Mar; 46(3):168-71. PubMed ID: 8027921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of SBE7-beta-cyclodextrin complexation on carbamazepine release from sustained release beads.
    Smith JS; Macrae RJ; Snowden MJ
    Eur J Pharm Biopharm; 2005 May; 60(1):73-80. PubMed ID: 15848059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
    Arima H; Yunomae K; Hirayama F; Uekama K
    J Pharmacol Exp Ther; 2001 May; 297(2):547-55. PubMed ID: 11303042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid dispersion of hydroxypropyl beta-cyclodextrin and ketorolac: enhancement of in-vitro dissolution rates, improvement in anti-inflammatory activity and reduction in ulcerogenicity in rats.
    Nagarsenker MS; Meshram RN; Ramprakash G
    J Pharm Pharmacol; 2000 Aug; 52(8):949-56. PubMed ID: 11007065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells.
    Motoyama K; Kameyama K; Onodera R; Araki N; Hirayama F; Uekama K; Arima H
    Eur J Pharm Sci; 2009 Oct; 38(3):249-61. PubMed ID: 19664706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential use of gamma-cyclodextrin polypseudorotaxane hydrogels as an injectable sustained release system for insulin.
    Abu Hashim II; Higashi T; Anno T; Motoyama K; Abd-ElGawad AE; El-Shabouri MH; Borg TM; Arima H
    Int J Pharm; 2010 Jun; 392(1-2):83-91. PubMed ID: 20298768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varying effects of cyclodextrin derivatives on aggregation and thermal behavior of insulin in aqueous solution.
    Tokihiro K; Irie T; Uekama K
    Chem Pharm Bull (Tokyo); 1997 Mar; 45(3):525-31. PubMed ID: 9085557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.